Stocks To Watch: Arrowhead Pharma Sees Relative Strength Rating Jump To 84Investors Business Daily • 03/23/20
Arrowhead Pharmaceuticals: Why JNJ-3989 May Become A First-Line Therapy For Chronic HBVSeeking Alpha • 02/25/20
Arrowhead Pharmaceuticals Q1 Results Didn't Matter -- but Its Pipeline Update DidThe Motley Fool • 02/06/20
Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/06/20
Sarepta Therapeutics, Inc. And Arrowhead Pharmaceuticals Now Top-Ranked Biotech Stock BuysSeeking Alpha • 02/01/20
Arrowhead Pharmaceuticals, Inc.: A Better Odds-On Capital-Gain Alternative To AlkermesSeeking Alpha • 01/28/20
This Highly Rated Biotech Company Just Tumbled 13% On A Public OfferingInvestors Business Daily • 12/02/19